Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Comment by clestoron Mar 13, 2013 6:01pm
226 Views
Post# 21125364

RE: RE: RE: RE: RE: RE: Do your diligence

RE: RE: RE: RE: RE: RE: Do your diligence

If I understand the merger agreement correctly . . .

If Aurizon doesn't get enough votes, then they only have to pay Hecla's expenses up to $8 mm.  If ARZ accepts a better offer or AGI acquires more than 33.33% of shares prior to the vote, then Hecla is entitled to the full $27.2 mm termination fee.  I wonder why ARZ didn't use a 19.9% cap instead of 33.3% cap.

If Mcclusky is telling the truth about having locked up 30% of ARZ shares, then its unlikely Aurizon will get enough votes for Hecla.  Hecla will get a wire transfer within 2 business days reimbursing them for their expenses.  At that point, HL can either raise their offer or go away.

ARZ bought themselves time with the HL deal and maybe they find another bidder.  But AGI should wait until after the HL vote to acquire more shares.

It seems AGI will eventually get ARZ for the price they have offered . . . just a question of how long it takes.

Using today's closing prices, the AGI offer is worth $4.64 per ARZ share and the HL offer is worth $4.62.  ARZ is trading at a 5.25% discount to the AGI offer.  If we think the AGI deal closes in 6 months, then the annualized return is roughly 10.5%.

Make sense?

 

Bullboard Posts